YOLFTbeta
68

Acer Medical Inc.

6857 · TWO · Healthcare / Health Information Services

89.90TWD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close89.90
Open89.90
Day Range89.90 – 89.90
52-Week Range89.00 – 128.00
Volume90
Market Cap1.42B
P/E (TTM)0.00
Forward P/E0.00
EPS-1.56
Dividend Yield0.00%
Beta0.69
50-Day Avg90.95
200-Day Avg96.85

About

Acer Medical Inc. offers artificial intelligence, clinical data, and software for healthcare sector. The company offers VeriSee DR, an AI-assisted diagnostic software for diabetic retinopathy identification; VeriSee AMD, an AI-assisted screening software for age-related macular degeneration identification; VeriSee GLC, an AI-assisted screening software for glaucoma suspect; and VeriOsteo OP, an AI-assisted screening software for bone mineral density abnormalities. It also provides aiMed, a generative AI platform for healthcare environments; aiGait, balance and gait assessment software; non-mydriatic automated portable fundus camera; and portable X-ray system solutions. Acer Medical Inc. was founded in 2018 and is based in New Taipei City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Yin Xiong Xu
  • HeadquartersNo. 88, Section 1, Xintai 5th Road, New Taipei City, Taiwan, Taiwan
  • Websitehttps://www.acer-medical.com

Leadership

  • Mr. Yin Xiong XuGeneral Manager
  • Mr. Ming Yuan ChenFinance & Accounting Manager
  • Mr. Yong Xin LiChief Operating Officer

Financials

Income Statement

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-1.01M9.63M13.06M27.45M50.16M60.05M
Growth (%)--+849.41%+35.66%+110.17%+82.73%+19.73%
Cost of Revenue-671.00K3.19M6.92M14.56M18.48M22.55M
Gross Profit-343.00K6.44M6.14M12.88M31.67M37.50M
Gross Margin-33.83%66.85%46.98%46.94%63.15%62.45%
Operating Expense-12.36M26.88M61.31M54.04M61.87M70.24M
Operating Income--12.02M-20.45M-55.18M-41.16M-30.20M-32.73M
Operating Margin--1185.21%-212.38%-422.49%-149.96%-60.20%-54.51%
EBITDA-5.53M-11.84M-20.37M-54.50M-39.85M-28.96M-28.44M
EBITDA Margin--1167.16%-211.59%-417.32%-145.19%-57.75%-47.35%
Net Income-5.63M-11.93M-20.45M-54.71M-38.18M-27.36M-29.69M
Net Income Margin--1176.04%-212.38%-418.88%-139.10%-54.56%-49.43%
R&D-10.95M13.63M26.30M20.54M26.85M29.94M
R&D as % of Total Revenue-1079.98%141.61%201.41%74.81%53.52%49.86%
Interest Expense1.00K1.00K00-013.00K
Interest Expense % of Total Revenue-0.10%0.00%0.00%-0.00%0.02%

Balance Sheet

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-43.54M136.73M290.16M259.43M226.89M207.23M
Total Liabilities89.00K14.31M21.95M30.04M37.49M32.30M42.30M
Total Equity-29.23M114.79M260.12M221.94M194.59M164.92M
Cash-89.00K43.36M49.68M276.56M220.03M202.78M176.15M
Total Debt89.00K---4.00K85.00K-
Net Debt178.00K-43.36M-49.68M-276.56M-220.02M-202.69M-

Cash Flow

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-2.79M-3.61M-18.82M-45.77M-53.13M-20.70M-24.65M
Investing Cash Flow-19.00M19.00M-80.86M72.63M-3.40M3.45M-
Financing Cash Flow-96.00K-89.00K106.00M200.01M4.00K--
Capital Expenditure00865.00K7.41M762.00K01.08M
Free Cash Flow-2.79M-3.61M-19.68M-53.17M-53.89M-20.70M-25.73M
FCF to OCF100.00%100.00%104.60%116.19%101.43%100.00%104.38%

Key Statistics & Ratios

Market Cap1.42B
Enterprise Value1.28B
Trailing P/E0.00
Forward P/E0.00
Price / Sales19.49
Price / Book9.19
EPS-1.56
Book Value10.23
Revenue (TTM)70.47M
Gross Profit (TTM)46.24M
EBITDA-25.97M
Profit Margin-33.62%
Operating Margin-25.83%
Return on Equity-14.14%
Return on Assets-8.30%
Shares Outstanding15.73M
Shares Float3.21M
Beta0.69
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%